1. Home
  2. UNCY vs MAMO Comparison

UNCY vs MAMO Comparison

Compare UNCY & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • MAMO
  • Stock Information
  • Founded
  • UNCY 2016
  • MAMO 2008
  • Country
  • UNCY United States
  • MAMO United States
  • Employees
  • UNCY N/A
  • MAMO N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • MAMO
  • Sector
  • UNCY Health Care
  • MAMO
  • Exchange
  • UNCY Nasdaq
  • MAMO NYSE
  • Market Cap
  • UNCY 91.0M
  • MAMO 91.0M
  • IPO Year
  • UNCY 2021
  • MAMO 2024
  • Fundamental
  • Price
  • UNCY $4.55
  • MAMO $2.79
  • Analyst Decision
  • UNCY Strong Buy
  • MAMO
  • Analyst Count
  • UNCY 4
  • MAMO 0
  • Target Price
  • UNCY $63.75
  • MAMO N/A
  • AVG Volume (30 Days)
  • UNCY 1.5M
  • MAMO 28.4K
  • Earning Date
  • UNCY 08-13-2025
  • MAMO 08-11-2025
  • Dividend Yield
  • UNCY N/A
  • MAMO N/A
  • EPS Growth
  • UNCY N/A
  • MAMO N/A
  • EPS
  • UNCY N/A
  • MAMO N/A
  • Revenue
  • UNCY N/A
  • MAMO $95,959,187.00
  • Revenue This Year
  • UNCY N/A
  • MAMO N/A
  • Revenue Next Year
  • UNCY $1,458.53
  • MAMO N/A
  • P/E Ratio
  • UNCY N/A
  • MAMO N/A
  • Revenue Growth
  • UNCY N/A
  • MAMO N/A
  • 52 Week Low
  • UNCY $2.02
  • MAMO $1.84
  • 52 Week High
  • UNCY $11.00
  • MAMO $4.66
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 39.53
  • MAMO N/A
  • Support Level
  • UNCY $4.76
  • MAMO N/A
  • Resistance Level
  • UNCY $7.15
  • MAMO N/A
  • Average True Range (ATR)
  • UNCY 0.97
  • MAMO 0.00
  • MACD
  • UNCY -0.28
  • MAMO 0.00
  • Stochastic Oscillator
  • UNCY 7.37
  • MAMO 0.00

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About MAMO MASSIMO GROUP

Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts, and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).

Share on Social Networks: